Log In
BCIQ
Print this Print this
 

Human anti-M2e antibody (TCN-032)

Also known as: influenza mAb

  Manage Alerts
Collapse Summary General Information
Company Theraclone Sciences Inc.
DescriptionRecombinant human mAb that specifically binds to a conserved epitope of the amino-terminal extracellular domain (M2e) of M2
Molecular Target Influenza A virus matrix protein M2 (M2)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase II
Standard IndicationInfluenza virus
Indication DetailsTreat influenza A infection; Treat influenza virus infection
Regulatory Designation
PartnerZenyaku Kogyo Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/05/2013

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today